Industry

CoSyne Therapeutics

A London drug discovery company pairing hyperscale single-cell perturbation data with custom foundation models to target underserved brain diseases.

Location: London, UK
Website
2 models(2 Single-cell, 1 DNA & Gene)

Models (2)

CoSyne Perturb-seq scFM

CoSyne Therapeutics

Released April 22, 2025

Single-cell foundation model contrastively fine-tuned on genome-scale Perturb-seq data to separate perturbed from unperturbed transcriptomic states.

Single-cell

Bio-DTA

CoSyne Therapeutics

Released April 17, 2025

Multi-modal single-cell foundation model that projects Enformer DNA embeddings into a transcriptome model token space to predict gene regulation.

Single-cellDNA & Gene